Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670602 · ClinicalTrials.gov registry record · NA
Weight Loss for Prediabetes Using Episodic Future Thinking
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03670602 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 64 participants.
The verdict
NCT03670602, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The goals of the UH3 are to assess the effectiveness of adding Episodic Future Thinking (EFT) to the investigators standard behavioral weight control program to improve weight loss, delay discounting (DD), working memory, glycemic control (HbA1c) and behavioral medication adherence over a 6 month period in persons with prediabetes and comorbid hypertension and/or hyperlipidemia. This will be accomplished by a randomized trial (N = 71 randomized) comparing the effects of EFT versus control that matches attention and use of technology.
Interventions
- BEHAVIORAL Episodic Future Thinking
- BEHAVIORAL Daily Check in
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2019-01-17 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03670602
The ClinicalTrials.gov registry entry for NCT03670602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Episodic Future Thinking is the first listed.
NCT03670602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03670602 about?
NCT03670602 is a clinical study titled "Weight Loss for Prediabetes Using Episodic Future Thinking". The goals of the UH3 are to assess the effectiveness of adding Episodic Future Thinking (EFT) to the investigators standard behavioral weight control program to improve weight loss, delay discounting (DD), working memory, glycemic control (HbA1c) and behavioral medication adherence over a 6 month pe...
What is the current status of trial NCT03670602?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2019-01-17. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03670602?
The interventions under investigation include: Episodic Future Thinking (BEHAVIORAL), Daily Check in (BEHAVIORAL).
Who is sponsoring clinical trial NCT03670602?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.